Sign in

Compass Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.07 0.06 0.05 0.04 0.08 0.03 0.03 0.04
Operating income -0.07 -0.06 -0.05 -0.04 -0.08 -0.03 -0.03 -0.04
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Income before tax -0.07 -0.05 -0.04 -0.04 -0.08 -0.03 -0.03 -0.04
Income tax expense 0.00 0.00 0.00 0.00 0.00
Net income -0.07 -0.05 -0.04 -0.04 -0.08 -0.03 -0.03 -0.04
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Jun-18
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.06 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Operating income -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.06 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 -0.02 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.06 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.02 -0.02 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.06 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.21 0.13 0.15 0.19 0.14 0.05 0.03 0.06
Accounts receivable, net 0.00
Other current assets 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00
Total current assets 0.21 0.13 0.15 0.19 0.15 0.05 0.03 0.06
Total non-current assets + 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.01
Total assets 0.22 0.14 0.16 0.20 0.15 0.05 0.03 0.06
Total current liabilities + 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01
Total non-current liabilities + 0.01 0.01 0.00 0.00 0.00 0.00 0.14 0.14
Total liabilities 0.02 0.02 0.01 0.02 0.01 0.01 0.15 0.15
Total stockholders' equity + 0.20 0.13 0.15 0.18 0.14 0.04 -0.12 -0.08
Common shares outstanding 158 137 127 105 63 56 52 5
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Dec-18 Sep-18 Jun-18
Total cash and short-term investments + 0.19 0.21 0.22 0.10 0.11 0.13 0.14 0.15 0.16 0.15 0.16 0.17 0.18 0.19 0.12 0.13 0.14 0.14 0.03 0.03 0.04 0.05 0.06 0.07 0.02 0.03 0.00 0.12 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00
Other current assets 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.20 0.21 0.22 0.11 0.12 0.13 0.14 0.15 0.16 0.15 0.17 0.18 0.18 0.19 0.12 0.13 0.14 0.15 0.03 0.03 0.04 0.05 0.06 0.07 0.02 0.03 0.00 0.00 0.00 0.00 0.00
Total non-current assets + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 -0.06
Total assets 0.21 0.22 0.23 0.12 0.13 0.14 0.15 0.16 0.16 0.16 0.17 0.18 0.19 0.20 0.13 0.14 0.15 0.15 0.03 0.04 0.05 0.05 0.06 0.07 0.02 0.03 0.00 0.00 0.00 0.00 0.00
Total current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.14
Total liabilities 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.15 0.00 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.19 0.20 0.21 0.09 0.11 0.13 0.14 0.15 0.16 0.15 0.16 0.17 0.18 0.18 0.12 0.13 0.13 0.14 0.02 0.03 0.03 0.04 0.05 0.05 0.01 -0.12 0.00 0.00 0.00 0.00 0.00
Common shares outstanding 186 185 138 138 138 137 138 138 137 128 127 127 126 105 101 101 101 52 62 52 51 61 61 52 52 61 52 52 5 5 5
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.05 -0.04 -0.04 -0.03 -0.02 -0.03 -0.03 -0.03
Cash flow from investing + -0.09 0.05 0.03 -0.15 0.00 0.00 0.00 0.00
Cash flow from financing + 0.13 0.02 0.00 0.08 0.12 0.05 0.00 0.06
Change in cash -0.01 0.02 -0.01 -0.11 0.10 0.02 -0.03 0.03
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Jun-18
Operating cash flow + -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00
Cash flow from investing + 0.04 0.00 -0.10 -0.01 0.01 0.02 0.03 0.01 0.00 0.01 0.02 0.00 0.00 -0.05 0.00 -0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.13 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.12 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00
Change in cash 0.02 -0.02 0.02 -0.02 0.00 0.01 0.02 0.00 0.00 -0.01 0.01 -0.01 -0.01 0.02 -0.01 -0.11 -0.01 0.12 -0.01 -0.01 -0.01 -0.01 -0.01 0.05 -0.01 -0.01 -0.01 0.00 0.00
5 days ago

Compass Therapeutics, Inc. (CMPX) - Research And Development

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Selling General And Administrative

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Operating Income

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Costof Goods And Services Sold

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Cost Of Revenue

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Total Revenue

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Gross Profit

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Long Term Debt

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Current Long Term Debt

1Y 2Y 5Y Max
9 days ago

Compass Therapeutics, Inc. (CMPX) - Property Plant Equipment

1Y 2Y 5Y Max
9 days ago